In this episode, we're joined by Dr Julie Denning, Managing Director and Chartered Health psychologist at Working2Wellbeing and chair of the Vocational Rehabilitation Association. Also joining us is Generali's own early intervention and rehabilitation expert, Kay Needle to discuss the latest thinking in support for employees with long-term conditions. Around 15 million people in England alone have a long-term condition. That's a condition that has to be managed with drugs or treatment such as diabetes, heart disease, stroke or cancer. And the number of people with three or more long-term conditions or multimorbidity, is ever-rising, bringing with it rising demand for prevention and management. Even long COVID, which is not as prevalent as any of these conditions but is arguably receiving most attention in the media, at least, is now verging into this territory and is also contributing to the wider discussion around chronic fatigue. Such conditions are more prevalent than others, but will undoubtedly impact people in most workplaces. So what are the trends? The latest thinking and support and barriers to progress?
Vocational Rehabilitation Association’s Post
More Relevant Posts
-
In this episode, we're joined by Dr Julie Denning, Managing Director and Chartered Health psychologist at Working2Wellbeing and chair of the Vocational Rehabilitation Association. Also joining us is Generali's own early intervention and rehabilitation expert, Kay Needle to discuss the latest thinking in support for employees with long-term conditions. Around 15 million people in England alone have a long-term condition. That's a condition that has to be managed with drugs or treatment such as diabetes, heart disease, stroke or cancer. And the number of people with three or more long-term conditions or multimorbidity, is ever-rising, bringing with it rising demand for prevention and management. Even long COVID, which is not as prevalent as any of these conditions but is arguably receiving most attention in the media, at least, is now verging into this territory and is also contributing to the wider discussion around chronic fatigue. Such conditions are more prevalent than others, but will undoubtedly impact people in most workplaces. So what are the trends? The latest thinking and support and barriers to progress?
Episode 7 - From Long Term Conditions To Multi-Morbidity
soundcloud.com
To view or add a comment, sign in
-
In this episode, we're joined by Dr Julie Denning, Managing Director and Chartered Health psychologist at Working2Wellbeing and chair of the Vocational Rehabilitation Association. Also joining us is Generali's own early intervention and rehabilitation expert, Kay Needle to discuss the latest thinking in support for employees with long-term conditions. Around 15 million people in England alone have a long-term condition. That's a condition that has to be managed with drugs or treatment such as diabetes, heart disease, stroke or cancer. And the number of people with three or more long-term conditions or multimorbidity, is ever-rising, bringing with it rising demand for prevention and management. Even long COVID, which is not as prevalent as any of these conditions but is arguably receiving most attention in the media, at least, is now verging into this territory and is also contributing to the wider discussion around chronic fatigue. Such conditions are more prevalent than others, but will undoubtedly impact people in most workplaces. So what are the trends? The latest thinking and support and barriers to progress?
Episode 7 - From Long Term Conditions To Multi-Morbidity
soundcloud.com
To view or add a comment, sign in
-
IHACPA is pleased to release the Pricing Framework for Australian Public Hospital Services 2024–25 following consultation. The key policy decisions outlined in this Pricing Framework include details on: • the intention to transition community mental health care from block funding to activity based funding using the Australian Mental Health Care Classification Version 1.0 following three years of shadow pricing • assessing and accounting for the impact of COVID-19 and other cost pressures on public hospital activity, costs and models of care • classification refinement, such as updates to the classifications used to price admitted subacute and non-acute care and non-admitted care. Access the Pricing Framework and the associated Consultation Report here: bit.ly/3Nlk3Yj
To view or add a comment, sign in
-
I partner with HCPs and individuals to treat pain, anxiety and insomnia with non-med, safe and scientifically proven Alpha-Stim
Wish you had something more to offer your patients struggling with their mental health and/or their sleep? Join this free webinar for healthcare professionals to learn how to easily incorporate Alpha-Stim. Your patients will love you for it! #patientsfirst , #bettersleep , #bringthecalm
Discover the transformative power of Alpha-Stim in this exclusive webinar presented by Dr. Benjamin Keizer, a board-certified Clinical Health Psychologist. Dr. Keizer will discuss how he seamlessly integrated Alpha-Stim as a standard of care, offering trials to nearly every patient and making it one of the most sought-after monotherapies in the center where he practices, and the remarkable ability of Alpha-Stim to treat anxiety, insomnia, and pain. Register here: https://lnkd.in/gGKcDwdZ
To view or add a comment, sign in
-
Another report, this time from the government of Denmark, showing that MDMA is proven to be effective and safe for PTSD. https://lnkd.in/eBP4GaJc Key findings of the report include: Harm from recreational ecstasy use in the Netherlands is limited, with no or very low dependence liability, no clinically relevant persistent cognitive deficits, and a limited number of serious incidents. MDMA-assisted therapy appears to be an effective and safe treatment for chronic and treatment-resistant PTSD patients. With approximately 400,000 people suffering from PTSD and less than 25% receiving evidence-based trauma treatment, there is a significant unmet need for PTSD treatment. The Dutch government should facilitate the introduction and use of MDMA-assisted therapy as soon as possible. Given the unlikely registration of this treatment with the European Medicines Agency soon, the committee proposes starting a large naturalistic study to provide MDMA treatment to those who need it most and to monitor PTSD patients receiving MDMA. #MDMA #psychedelics #PTSD #Denmark #MDMAassistedtherapy
MDMA /// Beyond Ecstasy
government.nl
To view or add a comment, sign in
-
There is poor understanding on health care utilization, productivity losses, and burden of adverse childhood experiences (ACEs) in multiethnic Asian populations. This open access study in Psychological Trauma, a publication of APA Division 56, aims to change that: https://bit.ly/4d1vsr0
To view or add a comment, sign in
-
I can help you create healthier workplaces where people feel connected and are better able to look after themselves, others and the company. Mental Health | Public Health | Audit and Policy | Training Specialist |
Another fantastic insight into #recovery from #mentalillness by the amazing Nicky Forsythe founder of TALK FOR HEALTH - the important of being witnessed and believed by those around you when you share about yourself and your #experiences. So often experiences are belittled, dismissed or overlooked by those who may not understand them or ever have lived through something similar. This can lead to people shying away from share of experiences and/or asking for help when they struggle with their #mentalhealth TALK FOR HEALTH we create places and forums where anyone can share what is happening for them be it the #goodstuff when our #wellbeing is high or our struggles when our #mentalhealth is not so great. We believe that everyone is deserving of attention and a place to share regardless of where they are in their #wellbeingjourney. #mentalhealthsupport #recoveryjourney #peersupport #peertopeer
Connection, being heard, and being believed - this is medicine for recovery. This week I’m sharing another personal story set in Italy that influenced the evolution of TALK FOR HEALTH 's programme in group therapeutic talking. You’re not alone. With Talk for Health, you’re joining like minded people who want to improve their wellbeing by developing empathic listening skills & sharing honestly. 1,000+ people have been through the T4H free programme since 2014, finding better mental health, solace and joy in community. If you'd like the Talk for Health medicine yourself or want to gift it to others this Christmas, you can buy the Book and Videos version of the programme at a special promotional rate of £40.0 Keep an eye on our Instagram feed @talk_for_health next week to order your copies! I’d love to talk to you about how you can help us reach even more people, providing therapy without therapists.
To view or add a comment, sign in
-
If you suspect you may be Neurodiverse and are thinking of visiting a health professional to be assessed there are things to be aware of and to look out for. Look for a practitioner who takes an holistic approach to assessment and treatment, considering all aspects of an individual's experiences and functioning, to help identify the most appropriate supports and interventions regardless of whether symptoms stem from trauma, neurodiversity, or a combination of both. Find out more about the difference between neurodiverse and Neurodiverse in our latest blog post by Anton Ashcroft https://lnkd.in/gGBqYe_U
To view or add a comment, sign in
-
Digital Health Leader | AI & Clinical Integration Expert | Champion of Healthcare Digitization & Value-Based Care | Technology & Service Delivery Optimization | Value-Based Care |
The Experience of Providing Physical Therapy in a Changing Health Care Environment. This study is 22 years old but is just as relevant in 2024. Finding professional meaning at the time of economic and professional change.
To view or add a comment, sign in
-
What are your thoughts on the Research Domain Criteria (#RDoC) initiative? Former NIMH director Dr. Thomas Insel created RDoC to address limitations in diagnostic algorithms such as the DSM. However, many of the same limitations identified by Dr. Insel might be applicable to other complex diseases. Do you think RDoC has been beneficial for mental health research and advancing clinical practice? Or, are there reasons to believe that RDoC may be more effective in addressing mental health concerns than other complex diseases? Share your perspective on this important topic, and thank you for weighing in! #mentalhealth #research #clinicalpractice #healthcare
To view or add a comment, sign in
5,022 followers